MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jconrel.2026.115306

Медицинская библиотека · Journal of controlled release : official journal of the Controlled Release Society · 2026

Spatially restricted antigen expression by an ionizable lipid nanoparticle enhances mRNA vaccine immunity against Pseudomonas aeruginosa.

Zhang Nana, Sun Ziwei, Fan Lianfeng, Miao Yu, Wei Anqi, Gao Xihui, Zhang Jiquan, Sun Yuansong, Wei Xiaoli

СтатьяПеревод в очереди

Аннотация

Pseudomonas aeruginosa is a major cause of hospital-acquired infections, yet no licensed vaccine is available. Although mRNA-LNP vaccines offer a flexible platform for antibacterial immunization, conventional formulations are primarily optimized for gene expression and often result in systemic antigen distribution. Here, we developed a novel ionizable lipid, LC3, that enables spatially confined antigen expression following intramuscular administration while enhancing immunostimulatory activity. Compared with SM102-based LNPs, mRNA-LNPLC3 achieved preferential antigen expression at the injection site and draining lymph nodes, with reduced hepatic expression. Mechanistic studies revealed a pronounced decoupling between cellular uptake and productive gene expression, where LC3-based LNPs showed comparable uptake but cell-context-dependent expression differences between hepatocytes and muscle cells, indicating that intracellular processing rather than uptake efficiency governs functional expression and underlies the liver-sparing profile. Single-cell RNA sequencing demonstrated that LNPLC3 vaccination induced a coordinated early immune activation program. Functionally, LNPLC3 elicited stronger humoral and cellular immune responses than LNPSM102 and conferred improved protection against P. aeruginosa, while maintaining a favorable safety profile. Collectively, these results demonstrate that LC3 enables spatially restricted antigen expression through cell-context-dependent intracellular processing, linking localized expression to enhanced immunostimulatory activity. LC3-based LNPs therefore integrate spatial control of antigen expression with improved immune activation, providing a rational strategy for mRNA-LNP vaccine design.

Для цитирования: Zhang Nana, Sun Ziwei, Fan Lianfeng, Miao Yu, Wei Anqi, Gao Xihui, Zhang Jiquan, Sun Yuansong, Wei Xiaoli. Spatially restricted antigen expression by an ionizable lipid nanoparticle enhances mRNA vaccine immunity against Pseudomonas aeruginosa.. Journal of controlled release : official journal of the Controlled Release Society. 2026. DOI: 10.1016/j.jconrel.2026.115306.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.